2004Zhongguo yaofangRequires access

Study on Bioequivalence of Polyferose Capsules

Yali Liu

Open publisher page 0 citations

Abstract

OBJECTIVE:To study the bioequivalence of polyferose capsule and imported Niferex in healthy volunˉteers.METHODS:In a randomized two-way crossover design,a single oral dose of150mg polyferose capsule(A)and Niferex(B)were given to20male healthy volunteers.The serum iron concentrations within12h after administration were determined with atomic absorption spectrometry and parameters C max ,T max ,AUC 0~t and AUC 0~∞ were obtained and analysed with two-one sided t test.RESULTS:The AUC 0~t ,C max ,T max ,T 1/2 and AUC 0~∞ of A and B were6.58μg/(h·ml)and6.58μg/(h·ml),1.07μg/ml and1.10μg/ml,3.93h and3.93h,2.33h and2.33h,6.95μg/(h·ml)and6.93μg/(h·ml)respectively.There were no significant difference between A and B(P0.05)and the differences of AUC 0~t ,T max and C max were not significant as verified by two-one sided t test.CONCLUSION:The relative bioequivalence of polyferose capsules is101.02%which indicates that polyferose capsule is a bioequivalent product of Niferex capsule.

About this research paper

What this paper is about

OBJECTIVE:To study the bioequivalence of polyferose capsule and imported Niferex in healthy volunˉteers.METHODS:In a randomized two-way crossover design,a single oral dose of150mg polyferose capsule(A)and Niferex(B)were given to20male healthy volunteers.The serum iron concentrations within12h after administration were determined with atomic absorption spectrometry and parameters C max ,T max ,AUC 0~t and AUC 0~∞ were obtained and analysed with two-one sided t test.RESULTS:The AUC 0~t ,C max ,T max ,T 1/2 and AUC 0~∞ of A and B were6.58μg/(h·ml)and6.58μg/(h·ml),1.07μg/ml and1.10μg/ml,3.93h and3.93h,2.33h and2.33h,6.95μg/(h·ml)and6.93μg/(h·ml)respectively.There were no significant difference between A and B(P0.05)and the differences of AUC 0~t ,T max and C max were not significant as verified by two-one sided t test.CONCLUSION:The relative bioequivalence of polyferose capsules is101.02%which indicates that polyferose capsule is a bioequivalent product of Niferex capsule.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To study the bioequivalence of polyferose capsule and imported Niferex in healthy volunˉteers.METHODS:In a randomized two-way crossover design,a single oral dose of150mg polyferose capsule(A)and Niferex(B)were given to20male healthy volunteers.The serum iron concentrations within12h after administration were determined with atomic absorption spectrometry and parameters C max ,T max ,AUC 0~t and AUC 0~∞ were obtained and analysed with two-one sided t test.RESULTS:The AUC 0~t ,C max ,T max ,T 1/2 and AUC 0~∞ of A and B were6.58μg/(h·ml)and6.58μg/(h·ml),1.07μg/ml and1.10μg/ml,3.93h and3.93h,2.33h and2.33h,6.95μg/(h·ml)and6.93μg/(h·ml)respectively.There were no significant difference between A and B(P0.05)and the differences of AUC 0~t ,T max and C max were not significant as verified by two-one sided t test.CONCLUSION:The relative bioequivalence of polyferose capsules is101.02%which indicates that polyferose capsule is a bioequivalent product of Niferex capsule.

Key concepts: Bioequivalence, Capsule, Crossover study, Chemistry, Pharmacokinetics, Absorption (acoustics), Pharmacology, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on Bioequivalence of Polyferose Capsules — Research Paper | ScholarLens